ELOS B Stock Overview
Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Elos Medtech AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr203.00 |
| 52 Week High | kr295.00 |
| 52 Week Low | kr185.00 |
| Beta | 1.12 |
| 1 Month Change | -5.14% |
| 3 Month Change | -8.14% |
| 1 Year Change | -17.31% |
| 3 Year Change | 96.14% |
| 5 Year Change | 195.92% |
| Change since IPO | 1,253.33% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)
Oct 11
Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?
May 23Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock
May 10Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)
Apr 17We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt
Mar 24Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?
Mar 11The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares
Feb 28Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?
Feb 24Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment
Feb 11When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?
Jan 31How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?
Jan 18
Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture
Jan 06Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?
Dec 26Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet
Dec 13Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 30Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 17Shareholder Returns
| ELOS B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0.5% | 3.3% | -0.7% |
| 1Y | -17.3% | -61.4% | 4.4% |
Return vs Industry: ELOS B underperformed the Swedish Medical Equipment industry which returned 2.5% over the past year.
Return vs Market: ELOS B underperformed the Swedish Market which returned 13.6% over the past year.
Price Volatility
| ELOS B volatility | |
|---|---|
| ELOS B Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.1% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: ELOS B has not had significant price volatility in the past 3 months.
Volatility Over Time: ELOS B's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1923 | 653 | Stefano Alfonsi | elosmedtech.com |
Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets. It offers implants, screws, plates, orthopedic and dental instruments, drills, pins and wires, dental prosthetics, disposable plastic products, HPLC fittings, and other medical plastic parts. The company also provides design and development, regulatory, prototyping, testing, OEM, process validation, and supply and inventory management, as well as design for manufacturing and engineering services.
Elos Medtech AB (publ) Fundamentals Summary
| ELOS B fundamental statistics | |
|---|---|
| Market cap | kr5.73b |
| Earnings (TTM) | kr54.95m |
| Revenue (TTM) | kr1.02b |
104.3x
P/E Ratio5.6x
P/S RatioIs ELOS B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ELOS B income statement (TTM) | |
|---|---|
| Revenue | kr1.02b |
| Cost of Revenue | kr676.62m |
| Gross Profit | kr341.02m |
| Other Expenses | kr286.07m |
| Earnings | kr54.95m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 29, 2024
| Earnings per share (EPS) | 1.95 |
| Gross Margin | 33.51% |
| Net Profit Margin | 5.40% |
| Debt/Equity Ratio | 51.6% |
How did ELOS B perform over the long term?
See historical performance and comparison